Patent File Information
Application Information
Applicants
Person No Name Address
6835989 JANSSEN PHARMACEUTICA NV
Inventors
Person No Name Address
7534531 Kim STUYCKENS C/O JANSSEN PHARMACEUTICA NV TURNHOUTSEWEG 30 2340 BEERSE BELÇİKA
7534532 Jose Juan PEREZ RUIXO C/O JANSSEN-CILAG, S.A. EDIFICIO JOHNSON & JOHNSON PASEO DE LAS DOCE ESTRELLAS, 5-7, 5° PLANTA CAMPO DE LAS NACIONES 28042 MADRID İSPANYA
7534536 O Arlene SIEFKER-RADTKE C/O JANSSEN PHARMACEUTICA NV TURNHOUTSEWEG 30 2340 BEERSE BELÇİKA
7534534 Narayan Anjali AVADHANI C/O JANSSEN PHARMACEUTICALS INC. SPRINGHOUSE CAMPUS 1400 MCKEAN ROAD SPRINGHOUSE PENNSYLVANIA 19477 A.B.D.
7534535 Yohann LORIOT C/O GUSTAVE ROUSSY 114, RUE ÉDOUARD-VAILLANT 94805 VILLEJUIF CEDEX FRANSA
7534533 Z Marie Peter DE PORRE C/O JANSSEN PHARMACEUTICA NV TURNHOUTSEWEG 30 2340 BEERSE BELÇİKA
Invention Information
Name Of Invention Kanser tedavisi
Summary Of Invention Konu olan buluş, kanserin erdafitinib ile tedavisi için bir usul sağlar.
Attorney Information
Name TOLGA ÇAYLAK
DIŞ PATENT MARKA TESCİL ve DANIŞMANLIK HİZ. LTD. ŞTİ.
Address GİRNE MAH. ELİFLİ SOK. NO:27 BAY PLAZA KAT:5-6-7 MALTEPE/ İSTANBUL
Priority Information
Date of Priority Priority Number Country of Priority
06-02-2017 US 201762455211P US
20-12-2017 EP 20170209098 EP
Classes of The Invention
IPC
A61K31/498
G01N33/574
A61P35/00
Patent Application Procedures
Date Date of Notification Operation Document
24-01-2025 Yıllık Ücret Ödeme Talebi
01-02-2024 Yıllık Ücret Ödeme Talebi
21-07-2023 Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
17-07-2023 EPO'dan Gelen Patent Fasikül
Publications
Publication Date Description
21-08-2023 Avrupa Patent Fasiküllerinin İlanı
Payment Dates
Row Year Payment Date Amount Paid (₺)
7 2024 01-02-2024 3321.89
8 2025 24-01-2025 6920.0